Control of hypertension in the critically ill: A pathophysiological approach

Annals of Intensive Care

Volumn 3, Issue 1, 2013, Pages 1-13

  Salgado, Diamantino Ribeiro ^a,b   Silva, Eliezer ^c   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Beta blockers; Calcium channel blockers; Cardiac output; Diuretics; Mean arterial pressure; Vasodilators

Indexed keywords

AMLODIPINE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BUMETANIDE; CLEVIDIPINE; CLONIDINE; DEXMEDETOMIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRILAT; ESMOLOL; FENOLDOPAM; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; METHYLDOPA; METOPROLOL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENTOLAMINE; PROPRANOLOL; URAPIDIL;

ACUTE KIDNEY FAILURE; AGRANULOCYTOSIS; ANEMIA; ANGINA PECTORIS; ANGIONEUROTIC EDEMA; ANXIETY; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR EFFECT; COCAINE DEPENDENCE; CONFUSION; CONSTIPATION; COUGHING; CRITICALLY ILL PATIENT; CUSHING SYNDROME; CYANIDE POISONING; DELIRIUM; DEPRESSION; DIARRHEA; DISEASE CONTROL; DIZZINESS; DROWSINESS; DRUG EXCRETION; DRUG HALF LIFE; DRY EYE; ERECTILE DYSFUNCTION; FATIGUE; FEVER; FLUSHING; HEADACHE; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART PRELOAD; HEART RATE; HEMOLYTIC ANEMIA; HEPATITIS; HUMAN; HYPERCAPNIA; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPERURICEMIA; HYPERVOLEMIA; HYPOGLYCEMIA; HYPOKALEMIA; HYPOTENSION; HYPOVOLEMIA; HYPOXEMIA; HYPOXIA; INSOMNIA; INTERSTITIAL NEPHRITIS; INTOXICATION; INTRACRANIAL HYPERTENSION; INTRAOCULAR PRESSURE; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER TOXICITY; LUPUS LIKE SYNDROME; METABOLIC ALKALOSIS; METHEMOGLOBINEMIA; MUSCLE SPASM; NAUSEA; NOSE OBSTRUCTION; ORTHOSTATIC HYPOTENSION; OTOTOXICITY; PAIN; PANCREATITIS; PARADOXICAL HYPERTENSION; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PRURITUS; PULMONARY HYPERTENSION; PULMONARY SHUNT; RASH; RAYNAUD PHENOMENON; RESPIRATORY DISTRESS; REVIEW; SCALP PRURITUS; SEDATION; SIDE EFFECT; ST SEGMENT; STRESS; SUBSTANCE ABUSE; TACHYCARDIA; TACHYPHYLAXIS; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL; URINE RETENTION; VASCULAR RESISTANCE; VOMITING; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 84881235015     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-3-17     Document Type: Review

References (71)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y: Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-e146.
3. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, Ezzati M: The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 2009, 6:e1000058.
4. Owens WB: Blood pressure control in acute cerebrovascular disease. J Clin Hypertens (Greenwich) 2011, 13:205-211.
5. Shafi T: Hypertensive urgencies and emergencies. Ethn Dis 2004, 14:S2-S7.
6. Styron JF, Jois-Bilowich P, Starling R, Hobbs RE, Kontos MC, Pang PS, Peacock WF: Initial emergency department systolic blood pressure predicts left ventricular systolic function in acute decompensated heart failure. Congest Heart Fail 2009, 15:9-13.
7. Szczech LA, Granger CB, Dasta JF, Amin A, Peacock WF, McCullough PA, Devlin JW, Weir MR, Katz JN, Anderson FA Jr, Wyman A, Varon J: Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation 2010, 121:2183-2191.
8. Vuylsteke A, Vincent JL, de La Payen GD, Anderson FA, Emery L, Wyman A, Rushton-Smith S, Gore JM: Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT). Crit Care 2011,15:R271.
9. Pollack CV, Varon J, Garrison NA, Ebrahimi R, Dunbar L, Peacock WF: Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med 2009, 53:329-338.
10. Katz JN, Gore JM, Amin A, Anderson FA, Dasta JF, Ferguson JJ, Kleinschmidt K, Mayer SA, Multz AS, Peacock WF, Peterson E, Pollack C, Sung GY, Shorr A, Varon J, Wyman A, Emery LA, Granger CB: Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J 2009, 158:599-606.
11. Gore JM, Peterson E, Amin A, Anderson FA Jr, Dasta JF, Levy PD, O'Neil BJ, Sung GY, Varon J, Wyman A, Granger CB: Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study. Am Heart J 2010, 160:521-527.
12. Mayer SA, Kurtz P, Wyman A, Sung GY, Multz AS, Varon J, Granger CB, Kleinschmidt K, Lapointe M, Peacock WF, Katz JN, Gore JM, O'Neil B, Anderson FA: Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension registry. Crit Care Med 2011, 39:2330-2336.
13. Peacock F, Amin A, Granger CB, Pollack CV Jr, Levy P, Nowak R, Kleinschmidt K, Varon J, Wyman A, Gore JM: Hypertensive heart failure: patient characteristics, treatment, and outcomes. Am J Emerg Med 2011, 29:855-862.
14. Varon J, Marik PE: Clinical review: the management of hypertensive crises. Crit Care 2003, 7:374-384.
15. Marik PE, Varon J: Hypertensive crises: challenges and management. Chest 2007,131:1949-1962.
16. Varon J: The diagnosis and treatment of hypertensive crises. Postgrad Med 2009, 121:5-13.
17. Papadopoulos DP, Mourouzis I, Thomopoulos C, Makris T, Papademetriou V: Hypertension crisis. Blood Press 2010, 19:328-336.
18. Johnson W, Nguyen ML, Patel R: Hypertension crisis in the emergency department. Cardiol Clin 2012, 30:533-543.
19. Camici PG, Crea F: Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840.
20. Ince C: The microcirculation is the motor of sepsis. Crit Care 2005, 9(Suppl 4):S13-S19.
21. Cohen JD: Overview of physiology, vascular biology, and mechanisms of hypertension. J Manag Care Pharm 2007, 13:S6-S8.
22. Liu Y, Gutterman DD: Vascular control in humans: focus on the coronary microcirculation. Basic Res Cardiol 2009, 104:211-227.
23. Robinson ES, Khankin EV, Karumanchi SA, Humphreys BD: Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker. Semin Nephrol 2010,30:591-601.
24. Pinsky MR: Hemodynamic evaluation and monitoring in the ICU. Chest 2007, 132:2020-2029.
25. Tibby SM, Murdoch IA: Monitoring cardiac function in intensive care. Arch Dis Child 2003, 88:46-52.
26. Strandgaard S, Olesen J, Skinhoj E, Lassen NA: Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973, 1:507-510.
27. Slama M, Modeliar SS: Hypertension in the intensive care unit. Curr Opin Cardiol 2006, 21:279-287.
28. Marik PE, Varon J: Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth 2009, 21:220-229.
29. Duncker DJ, Bache RJ: Regulation of coronary blood flow during exercise. Physiol Rev 2008, 88:1009-1086.
30. Cernaianu AC, Olah A, Cilley JH Jr, Gaprindashvili T, Gallucci JG, DelRossi AJ: Effect of sodium nitroprusside on paraplegia during cross-clamping of the thoracic aorta. Ann Thorac Surg 1993, 56:1035-1037.
31. Powers DR, Papadakos PJ, Wallin JD: Parenteral hydralazine revisited. J Emerg Med 1998, 16:191-196.
32. Wei S, Kasuya Y, Yanagisawa M, Kimura S, Masaki T, Goto K: Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery. Eur J Pharmacol 1997, 321:307-314.
33. Ludden TM, Shepherd AM, McNay JL, Lin MS: Hydralazine kinetics in hypertensive patients after intravenous administration. Clin Pharmacol Ther 1980, 28:736-742.
34. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P: Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003, 327:955-960.
35. Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T, Walkinshaw S: How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011, 72:394-401.
36. Shusterman NH, Elliott WJ, White WB: Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993, 95:161-168.
37. Oparil S, Aronson S, Deeb GM, Epstein M, Levy JH, Luther RR, Prielipp R, Taylor A: Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens 1999, 12:653-664.
38. Murphy MB, Murray C, Shorten GD: Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 2001, 345:1548-1557.
39. Hirschl MM, Binder M, Bur A, Herkner H, Brunner M, Mullner M, Sterz F, Laggner AN: Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises. Arch Intern Med 1995, 155:2217-2223.
40. Rhoney D, Peacock WF: Intravenous therapy for hypertensive emergencies, part 2. Am J Health Syst Pharm 2009, 66:1448-1457.
41. Narotam PK, Puri V, Roberts JM, Taylon C, Vora Y, Nathoo N: Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation. J Neurosurg 2008, 109:1065-1074.
42. Varon J, Marik PE: Perioperative hypertension management. Vasc Health Risk Manag 2008, 4:615-627.
43. Curran MP, Robinson DM, Keating GM: Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications. Drugs 2006, 66:1755-1782.
44. Peacock WF, Varon J, Baumann BM, Borczuk P, Cannon CM, Chandra A, Cline DM, Diercks D, Hiestand B, Hsu A, Jois-Bilowich P, Kaminski B, Levy P, Nowak RM, Schrock JW: CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department. Crit Care 2011, 15:R157.
45. Cannon CM, Levy P, Baumann BM, Borczuk P, Chandra A, Cline DM, Diercks DB, Hiestand B, Hsu A, Jois P, Kaminski B, Nowak RM, Schrock JW, Varon J, Peacock WF: Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial. BMJ Open 2013, 3:e002338.
46. Malesker MA, Hilleman DE: Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients. J Crit Care 2012, 27:528. e7-14.
47. Deeks ED, Keating GM, Keam SJ: Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs 2009, 9:117-134.
48. Awad AS, Goldberg ME: Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review. Vasc Health Risk Manag 2010, 6:457-464.
49. Nguyen HM, Ma K, Pham DQ: Clevidipine for the treatment of severe hypertension in adults. Clin Ther 2010, 32:11-23.
50. Aronson S, Dyke CM, Stierer KA, Levy JH, Cheung AT, Lumb PD, Kereiakes DJ, Newman MF: The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 2008, 107:1110-1121.
51. Peacock F, Varon J, Ebrahimi R, Dunbar L, Pollack CV Jr: Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis. Congest Heart Fail 2010, 16:55-59.
52. Peacock WF, Varon J, Ebrahimi R, Dunbar L, Pollack CV Jr: Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis. Blood Press Suppl 2011, 1:20-25.
53. Pedersen ME, Cockcroft JR: The latest generation of beta-blockers: new pharmacologic properties. Curr Hypertens Rep 2006, 8:279-286.
54. Che Q, Schreiber MJ Jr, Rafey MA: Beta-blockers for hypertension: are they going out of style? Cleve Clin J Med 2009, 76:533-542.
55. Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH: Beta-blockers for hypertension. Cochrane Database Syst Rev 2012, 11, CD002003.
56. Varon J: Treatment of acute severe hypertension: current and newer agents. Drugs 2008, 68:283-297.
57. Chrysant SG, Chrysant GS, Dimas B: Current and future status of beta-blockers in the treatment of hypertension. Clin Cardiol 2008, 31:249-252.
58. Rodriguez MA, Kumar SK, De Caro M: Hypertensive crisis. Cardiol Rev 2010, 18:102-107.
59. Gray RJ: Managing critically ill patients with esmolol, An ultra short-acting beta-adrenergic blocker. Chest 1988, 93:398-403.
60. Pearce CJ, Wallin JD: Labetalol and other agents that block both alpha-and beta-adrenergic receptors. Cleve Clin J Med 1994, 61:59-69.
61. McMillian WD, Trombley BJ, Charash WE, Christian RC: Phentolamine continuous infusion in a patient with pheochromocytoma. Am J Health Syst Pharm 2011, 68:130-134.
62. Mazza A, Armigliato M, Zamboni S, Rempelou P, Rubello D, Pessina AC, Casiglia E: Endocrine arterial hypertension: therapeutic approach in clinical practice. Minerva Endocrinol 2008, 33:297-312.
63. Dooley M, Goa KL: Urapidil, A reappraisal of its use in the management of hypertension. Drugs 1998, 56:929-955.
64. Jhund PS, McMurray JJ, Davie AP: The acute vascular effects of frusemide in heart failure. Br J Clin Pharmacol 2000, 50:9-13.
65. Tamagawa Y, Saino T, Matsuura M, Satoh Y: The effects of diuretics on intracellular Ca2+ dynamics of arteriole smooth muscles as revealed by laser confocal microscopy. Acta Histochem Cytochem 2009, 42:121-128.
66. Gregoretti C, Moglia B, Pelosi P, Navalesi P: Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug. Curr Drug Targets 2009, 10:799-814.
67. Prichard BN, Graham BR: I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly. Drugs Aging 2000, 17:133-159.
68. Jamadarkhana S, Gopal S: Clonidine in adults as a sedative agent in the intensive care unit. J Anaesthesiol Clin Pharmacol 2010, 26:439-445.
69. Cline JC, Connelly J: Intravenous clonidine for hypertensive emergencies. Am J Health Syst Pharm 1999, 56:572-574.
70. Farag E, Chahlavi A, Argalious M, Ebrahim Z, Hill R, Bourdakos D, Woo H: Using dexmedetomidine to manage patients with cocaine and opioid withdrawal, who are undergoing cerebral angioplasty for cerebral vasospasm. Anesth Analg 2006, 103:1618-1620.
71. Khan IA, Nair CK: Clinical, diagnostic, and management perspectives of aortic dissection. Chest 2002, 122:311-328.